venBio Global Strategic Fund, L.P. → Akero Therapeutics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Akero Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2021-06-29	SC	ATP Life Science Ventures, L.P.	—	—	view →
2021-05-07	SC	venBio Global Strategic Fund II L.P.	—	—	view →
2020-09-09	SC	venBio Global Strategic Fund II L.P.	—	—	view →
2020-01-15	SC	venBio Global Strategic Fund II L.P.	—	—	view →

Other Filings by venBio Global Strategic Fund, L.P.

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13D/A	ALX ONCOLOGY HOLDINGS INC	9.99%	4,307,034	view →
2020-07-09	SC	PRECISION BIOSCIENCES INC DTIL	—	—	view →
2020-06-24	SC	PRECISION BIOSCIENCES INC DTIL	—	—	view →
2020-06-08	SC	PRECISION BIOSCIENCES INC DTIL	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →